3.45

1.42% -0.07

Goodrx Holdings Inc (GDRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GDRX? Forum Prognose

Schlusskurs vom Vortag:

$3.52

Offen:

$3.53

24-Stunden-Volumen:

86,323

Relative Volume:

0.06

Marktkapitalisierung:

$1.18B

Einnahmen:

$787.89M

Nettoeinkommen (Verlust:

$20.56M

KGV:

58.97

EPS:

0.0585

Netto-Cashflow:

$96.54M

1W Leistung:

+0.58%

1M Leistung:

-5.71%

6M Leistung:

+47.66%

1J Leistung:

-15.98%

1-Tages-Spanne:

$3.435

$3.53

1-Wochen-Bereich:

$3.43

$3.58

52-Wochen-Spanne:

$1.77

$5.8099

Goodrx Holdings Inc Stock (GDRX) Company Profile

Firmenname

Goodrx Holdings Inc

Sektor

Healthcare (1087)

Branche

Health Information Services (47)

Telefon

(855) 268-2822

Adresse

2701 OLYMPIC BOULEVARD, SANTA MONICA

Mitarbeiter

697

Twitter

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

GDRX's Discussions on Twitter

Compare GDRX vs VEEV, BTSG, TEM, TXG, HQY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GDRX Goodrx Holdings Inc	3.45	1.20B	787.89M	20.56M	96.54M	0.0585
VEEV Veeva Systems Inc	263.73	42.88B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	61.45	12.38B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	64.89	11.67B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	65.33	8.55B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	92.42	7.72B	1.34B	230.70M	440.96M	2.6695

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-27	Herabstufung	JP Morgan	Overweight → Neutral
2026-01-22	Herabstufung	Jefferies	Buy → Hold
2025-12-09	Eingeleitet	Barclays	Underweight
2025-08-11	Herabstufung	Raymond James	Strong Buy → Outperform
2024-12-04	Eingeleitet	Mizuho	Neutral
2024-08-09	Hochstufung	Raymond James	Outperform → Strong Buy
2024-05-23	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-05-16	Hochstufung	Raymond James	Mkt Perform → Outperform
2024-04-10	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2024-03-25	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-03-01	Hochstufung	JP Morgan	Neutral → Overweight
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-01-02	Herabstufung	BofA Securities	Buy → Underperform
2023-08-10	Hochstufung	DA Davidson	Neutral → Buy
2023-07-31	Hochstufung	TD Cowen	Market Perform → Outperform
2022-12-01	Eingeleitet	Citigroup	Buy
2022-11-04	Hochstufung	JP Morgan	Underweight → Neutral
2022-09-16	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2022-09-07	Eingeleitet	Truist	Hold
2022-08-12	Eingeleitet	DA Davidson	Neutral
2022-06-10	Herabstufung	Goldman	Buy → Neutral
2022-06-06	Fortgesetzt	BofA Securities	Buy
2022-06-01	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-05-10	Herabstufung	Evercore ISI	Outperform → In-line
2022-05-10	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-05-10	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-05-10	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2022-04-11	Eingeleitet	Wells Fargo	Equal Weight
2022-04-07	Eingeleitet	Guggenheim	Buy
2022-04-01	Fortgesetzt	Credit Suisse	Neutral
2022-03-15	Hochstufung	Robert W. Baird	Neutral → Outperform
2022-03-01	Bestätigt	Barclays	Overweight
2022-03-01	Bestätigt	BofA Securities	Neutral
2022-03-01	Herabstufung	Cowen	Outperform → Market Perform
2022-03-01	Herabstufung	Credit Suisse	Outperform → Neutral
2022-03-01	Bestätigt	Evercore ISI	Outperform
2022-03-01	Bestätigt	Goldman	Buy
2022-03-01	Bestätigt	JP Morgan	Underweight
2022-03-01	Bestätigt	RBC Capital Mkts	Outperform
2022-03-01	Bestätigt	SVB Leerink	Outperform
2022-01-07	Eingeleitet	Goldman	Buy
2021-12-21	Eingeleitet	Stephens	Overweight
2021-12-02	Eingeleitet	Jefferies	Buy
2021-08-31	Hochstufung	Barclays	Equal Weight → Overweight
2021-08-13	Hochstufung	Raymond James	Mkt Perform → Outperform
2021-05-28	Eingeleitet	Robert W. Baird	Neutral
2021-04-06	Fortgesetzt	Evercore ISI	Outperform
2021-01-25	Eingeleitet	Guggenheim	Buy
2020-11-19	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2020-11-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-10-19	Eingeleitet	Barclays	Equal Weight
2020-10-19	Eingeleitet	BofA Securities	Neutral
2020-10-19	Eingeleitet	Citigroup	Buy
2020-10-19	Eingeleitet	Cowen	Outperform
2020-10-19	Eingeleitet	Credit Suisse	Outperform
2020-10-19	Eingeleitet	Deutsche Bank	Hold
2020-10-19	Eingeleitet	Goldman	Neutral
2020-10-19	Eingeleitet	JP Morgan	Neutral
2020-10-19	Eingeleitet	Morgan Stanley	Overweight
2020-10-19	Eingeleitet	RBC Capital Mkts	Sector Perform
2020-10-19	Eingeleitet	SVB Leerink	Outperform
2020-10-19	Eingeleitet	UBS	Buy

Alle ansehen

Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten

Sep 06, 2026

InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - Investing.com Australia

Sep 06, 2026

Sep 03, 2026

GoodRx offers health subscription for families, to launch as employee benefit in 2027 - Reuters

Sep 03, 2026

GDRX Looks 34.8% Undervalued on GF Value™ - GuruFocus

Sep 03, 2026

One plan covers kids, adults and pets. GoodRx's new membership costs $24.99 a month. - Stock Titan

Sep 03, 2026

Aug 31, 2026

Promising Penny Stocks To Consider In August 2026 - simplywall.st

Aug 31, 2026

Aug 27, 2026

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX) - The Globe and Mail

Aug 27, 2026

Aug 26, 2026

GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com India

Aug 26, 2026

Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale - Stock Titan

Aug 26, 2026

Aug 24, 2026

GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Moomoo

Aug 24, 2026

Aug 23, 2026

GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingROE Trend Analysis - vinanet.vn

Aug 23, 2026

Aug 21, 2026

Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat

Aug 19, 2026

Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn

Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move: Shares Move Lower 1.88% in Latest TradingShare Repurchase Impact - siam.in

Aug 18, 2026

Aug 17, 2026